The Farmington biotech startup Rallybio reports it is working on drug discovery with Exscientia an artificial intelligence company in the United Kingdom.
Steve Uden, chief operating officer at Rallybio, said he believes the venture “will accelerate the development of life-transforming therapies for patients suffering from severe and rare disorders.” more